We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.43%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.01B
AUM Growth
+$319M
(+5.6%)
Cap. Flow
+$303M
Cap. Flow
% of AUM
5.05%
Top 10 Holdings %
Top 10 Hldgs %
12.12%
Holding
1,131
New
156
Increased
425
Reduced
373
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$34.8M |
| 2 |
Cigna
CI
|
+$31.8M |
| 3 |
UnitedHealth
UNH
|
+$26.4M |
| 4 |
AutoZone
AZO
|
+$24.3M |
| 5 |
Eli Lilly
LLY
|
+$21.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$34.9M |
| 2 |
McKesson
MCK
|
+$25.9M |
| 3 |
XL
XL Group Ltd.
XL
|
+$25.4M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$22M |
| 5 |
AT&T
T
|
+$17.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.15% |
| 2 | Financials | 18.28% |
| 3 | Industrials | 13.53% |
| 4 | Consumer Discretionary | 11.12% |
| 5 | Healthcare | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
901
DELISTED
bluebird bio
BLUE
| $229K | ﹤0.01% |
+103
| New | +$262K |
|
902
Stagwell
STGW
$1.84B
| $229K | ﹤0.01% |
31,856
-120,686
| -79% | -$1.03M |
|
903
Fortress Biotech
FBIO
$111M
| $228K | ﹤0.01% |
3,345
-2,666
| -44% | -$169K |
|
904
Radiant Logistics
RLGT
$416M
| $228K | ﹤0.01% |
59,000
-100,712
| -63% | -$429K |
|
|
UCTT
905
Ultra Clean Holdings
UCTT
$4.16B
| $228K | ﹤0.01% |
11,870
| – | – |
|
906
Mercantile Bank Corp
MBWM
$1.01B
| $226K | ﹤0.01% |
+6,805
| New | +$238K |
|
907
Assured Guaranty
AGO
$3.78B
| $224K | ﹤0.01% |
6,190
-233,553
| -97% | -$8.23M |
|
908
SandRidge Energy
SD
$510M
| $223K | ﹤0.01% |
15,400
-17,600
| -53% | -$297K |
|
909
Shutterstock
SSTK
$205M
| $221K | ﹤0.01% |
+4,580
| New | +$216K |
|
|
FBNK
910
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $221K | ﹤0.01% |
8,635
-2,500
| -22% | -$65.2K |
|
911
MSCI
MSCI
$40B
| $220K | ﹤0.01% |
1,470
-120
| -8% | -$17.2K |
|
|
PFNX
912
DELISTED
Pfenex Inc.
PFNX
| $217K | ﹤0.01% |
36,192
-49,140
| -58% | -$193K |
|
|
OMED
913
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $217K | ﹤0.01% |
68,200
+19,800
| +41% | +$54.6K |
|
|
SHLO
914
DELISTED
Shiloh Industries Inc
SHLO
| $215K | ﹤0.01% |
24,754
-13,600
| -35% | -$106K |
|
|
CCXI
915
DELISTED
ChemoCentryx, Inc.
CCXI
| $214K | ﹤0.01% |
15,708
-19,100
| -55% | -$197K |
|
916
Brighthouse Financial
BHF
$3.63B
| $213K | ﹤0.01% |
+4,140
| New | +$239K |
|
917
Quaker Houghton
KWR
$2.63B
| $212K | ﹤0.01% |
1,429
-1,400
| -49% | -$212K |
|
918
Lisata Therapeutics
LSTA
$15.2M
| $212K | ﹤0.01% |
2,425
-87
| -3% | -$6.03K |
|
919
Geospace Technologies
GEOS
$91.6M
| $211K | ﹤0.01% |
+21,365
| New | +$262K |
|
920
Alkermes
ALKS
$8.82B
| $209K | ﹤0.01% |
+3,610
| New | +$211K |
|
921
Peoples Bancorp
PEBO
$1.45B
| $208K | ﹤0.01% |
+5,860
| New | +$205K |
|
|
PSB
922
DELISTED
PS Business Parks, Inc.
PSB
| $207K | ﹤0.01% |
1,830
-8,930
| -83% | -$1.03M |
|
923
Aviat Networks
AVNW
$262M
| $206K | ﹤0.01% |
24,614
-4,400
| -15% | -$36.8K |
|
924
First Community Bankshares
FCBC
$915M
| $204K | ﹤0.01% |
6,819
-1,128
| -14% | -$32K |
|
925
Tempest Therapeutics
TPST
$14.8M
| $204K | ﹤0.01% |
86
+38
| +79% | +$114K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2018 Portfolio in Review
As of Q1 2018, Jacobs Levy Equity Management held 1,131 positions worth $6.01B, up 5.6% from $5.69B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $303M of net new capital in Q1 2018, opening 156 new positions and adding to 425 existing holdings. Its largest new stake was Cigna: 163,820 shares worth $27.5M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was ExxonMobil, an estimated $34.9M trimmed.
- Jacobs Levy Equity Management's largest Q1 2018 buy was Cigna: 163,820 shares worth $27.5M.
- Jacobs Levy Equity Management added most to Microsoft in Q1 2018, an estimated $34.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2018 reduction was ExxonMobil, cutting an estimated $34.9M.
- Jacobs Levy Equity Management fully exited XL Group Ltd. in Q1 2018, selling an estimated $25.4M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $6.01B portfolio in Q1 2018.
- Jacobs Levy Equity Management opened 156 new positions and closed 143 in Q1 2018.
- Jacobs Levy Equity Management's portfolio value rose 5.6% quarter-over-quarter to $6.01B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2018, filed 15 May 2018.